Issue 1/2011

Secondary malignancies after hematopoietic stem cell transplantation (1 — 8)

L. ROZIAKOVA, E. BOJTAROVA, M. MISTRIK, B. MLADOSIEVICOVA

DOI: 10.4149/neo_2011_01_1

Olfactomedin 4, a novel marker for the differentiation and progression of gastrointestinal cancers (9 — 13)

L. YU, L. WANG, S. CHEN

DOI: 10.4149/neo_2011_01_9

Ex vivo assessment of protective effects of carvacrol against DNA lesions induced in primary rat cells by visible light excited methylene blue (VL+MB) (14 — 19)

D. SLAMENOVA, E. HORVATHOVA, I. CHALUPA, L. WSOLOVA, J. NAVAROVA

DOI: 10.4149/neo_2011_01_14

Omental milky spots in screening gastric cancer stem cells (20 — 26)

L. CAO, X. HU, Y. ZHANG, X. T. SUN

DOI: 10.4149/neo_2011_01_20

EGFR and HER-2 status of non-small cell lung cancer brain metastasis and corresponding primary tumor (27 — 34)

J. S. KOO, S. H. KIM

DOI: 10.4149/neo_2011_01_27

Epigenetic modulation of gene expression of human leukemia cell lines – induction of cell death and senescence (35 — 44)

K. ELKNEROVA, D. MYSLIVCOVA, Z. LACINOVA, I. MARINOV, L. UHERKOVA, P. STÖCKBAUER

DOI: 10.4149/neo_2011_01_35

Evaluation of TNF superfamily molecules release by neutrophils and B leukemic cells of patients with chronic B – cell lymphocytic leukemia (45 — 50)

J. SAWICKA-POWIERZA, E. JABLONSKA, J. KLOCZKO, J. PISZCZ, M. GARLEY, W. RATAJCZK-WRONA

DOI: 10.4149/neo_2011_01_45

Fine-needle aspiration biopsy of cervical lymph nodes: factors in predicting malignant diagnosis (51 — 57)

B. K. ARIBAŞ, K. ARDA, N. ÇILEDAĞ, M. F. ÇETINDAĞ, K. DOĞAN, G. ŞAHIN, Z. YOLOĞLU, E. AKTAŞ

DOI: 10.4149/neo_2011_01_51

Leptin and adiponectin in pancreatic cancer: connection with diabetes mellitus (58 — 64)

T. KRECHLER, M. ZEMAN, M. VECKA, J. MACASEK, M. JACHYMOVA, T. ZIMA, A. ZAK

DOI: 10.4149/neo_2011_01_58

The role of p27Kip1 phosphorylation at Serine 10 in the migration of malignant glioma cells in vitro (65 — 73)

D. WANG, F. HE, L. ZHANG, F. ZHANG, Q. WANG, X. QIAN, X. PAN, J. MENG, C. PENG, A. SHEN, J. CHEN

DOI: 10.4149/neo_2011_01_65

The different clinical significance of EGFR mutations in exon 19 and 21 in non-small cell lung cancer patients of China (74 — 81)

M. LI, Q. ZHANG, L. LIU, Z. LIU, L. ZHOU, Z. WANG, S. YUE, H. XIONG, L. FENG, S. LU

DOI: 10.4149/neo_2011_01_74

Cytogenetic abnormalities predict treatment-free interval and response to therapy in previously untreated chronic lymphocytic leukemia patients (82 — 88)

M. GIERTLOVA, M. HAJIKOVA, J. VASKOVA, A. KAFKOVA, N. STECOVA, L. MIROSSAY, A. KARABINOS, E. TOTHOVA, M. SARISSKY

DOI: 10.4149/neo_2011_01_82

Research on the reactivation of Syk expression caused by the inhibition of DNA promoter methylation in the lung cancer (89 — 95)

S. W. DONG, L. MA, N. XU, H. Q. YAN, H. Y. LIU, Y. W. LI, P. ZHANG

DOI: 10.4149/neo_2011_01_89